This inventor holds 1 USPTO granted patent. Top assignee: William Harvey Research Limited. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovations of Roger Corder
Introduction
Roger Corder is a notable inventor based in Harrow, GB. He has made significant contributions to the field of medical research, particularly in the area of endothelin-1 synthesis. His work has the potential to impact the treatment of various diseases linked to the overproduction of this peptide.
Latest Patents
Corder holds a patent for "Inhibitors of endothelin-1 synthesis." This patent describes sequences in human preproendothelin-1 mRNA that can be targeted by antisense oligonucleotides to inhibit the synthesis of endothelin-1. The inhibition of endothelin-1 synthesis may be utilized to treat diseases where excess production of endothelin-1 is a contributing factor to the symptoms. He has 1 patent to his name.
Career Highlights
Roger Corder is associated with William Harvey Research Limited, where he continues to advance his research and innovations. His work is crucial in understanding the mechanisms behind endothelin-1 and its implications in various health conditions.
Collaborations
Corder has collaborated with esteemed colleagues such as Adrian P L Smith and Timothy W Higgenbottam. These collaborations have further enriched his research and contributed to the development of innovative solutions in the medical field.
Conclusion
Roger Corder's contributions to the field of endothelin-1 synthesis represent a significant advancement in medical research. His innovative work holds promise for the treatment of diseases associated with endothelin-1 overproduction.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile